...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZEN-3694 and Enzalutamide 2b Trial
Reply New Message
Back To Forum List View
Icon president ZEN-3694 and Enzalutamide 2b Trial
5
RVXoldtimer
Apr 22, 2021 10:04AM

"The clinical study is expected to start in Q2 2021."

Do we know the duration of the Phase 2b randomized study?

 

Koo

3 Recommendations
Re: ZEN-3694 and Enzalutamide 2b Trial - Astella owns a piece of Xtandi (aka Enzalutamide)
3
Payzone
Apr 22, 2021 12:30PM
Re: ZEN-3694 and Enzalutamide 2b Trial - Astella owns a piece of Xtandi (aka Enzalutamide)
5
fuzzyjr
Apr 22, 2021 01:18PM
Icon president Re: ZEN-3694 and Enzalutamide 2b Trial - Astella owns a piece of Xtandi (aka Enzalutamide)
8
RVXoldtimer
Apr 22, 2021 01:50PM
Icon president Re: ZEN-3694 and Enzalutamide 2b Trial
6
BearDownAZ
Apr 22, 2021 04:31PM
Icon president Re: ZEN-3694 and Enzalutamide 2b Trial
7
RVXoldtimer
Apr 22, 2021 06:35PM
Icon president Re: ZEN-3694 and Enzalutamide 2b Trial
7
BearDownAZ
Apr 23, 2021 07:56AM
Icon president Re: ZEN-3694 and Enzalutamide 2b Trial
6
RVXoldtimer
Apr 23, 2021 12:24PM
Re: ZEN-3694 and Enzalutamide 2b Trial
6
fouremm
Apr 23, 2021 01:16PM
Re: ZEN-3694 and Enzalutamide 2b Trial
3
narmac
Apr 23, 2021 08:34PM
Re: ZEN-3694 and Enzalutamide 2b Trial
6
fouremm
Apr 26, 2021 11:22AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply